Category Archives: Health

01Feb/21

In Honor of American Heart Month, Lipton & The Singing Surgeons Release Cover Album “Put A Little Love in Your Heart”

The brand has teamed up with the viral singing duo, Dr. Elvis Francois and Dr. William Robinson, to record a heart-inspired cover album to encourage people to care for their heart health Continue reading

22Jan/21

Sky Medical Technology and Barnsley Hospital NHS Foundation Trust shortlisted for Bionow award for obstetrics blood clot prevention study

HIGH WYCOMBE, England, Jan. 22, 2021 /PRNewswire/ — Sky Medical Technology (Sky) has been shortlisted for the Healthcare Project of the Year at the Bionow awards, for its work with Barnsley Hospital NHS Foundation Trust Maternity Unit with the winning project due to be announced on the 4th February. Continue reading

11Jan/21

Empire State Building to Shine in a Red Heartbeat to Honor President-Elect Joe Biden’s COVID-19 Memorial

Music-to-Light Show Synced to Alicia Keys’ ‘Empire State of Mind’ Returns With Simulcast on iHeartMedia New York’s Z100 and the iHeartRadio App

NEW YORK, Jan. 11, 2021 /PRNewswire/ — The Empire State Building today announced its participation in President-Elect Biden’s plan to memorialize American lives lost from the COVID-19 pandemic with its iconic heartbeat lighting. For several months during New York City’s direst period, the Empire State Building’s heartbeat exhibited solidarity with and support for the millions of people affected by COVID-19, and specifically the emergency workers who addressed the first, great assault of the pandemic. Continue reading

14Dec/20

Elsevier acquires Shadow Health, a leading provider of best-in-class healthcare simulations

Elsevier, a global leader in research publishing and information analytics, and part of RELX, has acquired Shadow Health, a Florida-based developer of virtual simulations in nursing and healthcare education.

Shadow Health’s Digital Clinical Experiences train and prepare nurses and healthcare practitioners for clinical settings. Its cutting-edge simulations, powered by Shadow Health’s Conversation Engine, enable learners to practice and apply their clinical reasoning skills through life-like interactions with a diverse range of virtual patients. Engaging in conversation-based learning, students gain confidence by practicing the skills they need to care for patients in a safe and standardized environment. Read more

19Oct/20

Stryker launches industry’s first completely wireless hospital bed

Stryker, one of the world’s leading medical technology companies, today announced the global launch of the industry’s first and only completely wireless hospital bed, ProCuity™. This intelligent bed was designed to help reduce in-hospital patient falls at all acuity levels, improve nurse workflow efficiencies and safety, as well as help lower hospital costs. It is the only bed on the market today that can connect seamlessly to nurse call systems without the use of cables or wires.  Read more

19Oct/20

MED-EL: First Surgeries Ever in Europe with a Totally Implantable Cochlear Implant

Leading hearing implant manufacturer MED-EL sets another revolutionary milestone in its long-standing history of technological innovations. On 24 September, the first person in Europe received a novel totally implantable cochlear implant (TICI). It was implanted by Prof. Dr. Philippe Lefebvre, head of the ENT Department of the CHU of Liège and Professor at the University of Liège in Belgium within a feasibility study. The TICI is expected to give users great hearing with even more comfort. However, it will take several years before it receives market approval. Read more

21Sep/20

Axon Neuroscience to launch world’s first crowdfunded vaccine against COVID-19

AXON Neuroscience (“Axon”), a clinical-stage biotech company and an industry leader in treating and preventing neurodegenerative diseases with a unique peptide vaccine platform, is launching the world’s first independently-developed crowdfunded vaccine against COVID-19 – ACvac1. Read more

08Aug/20

Janssen Announces U.S. FDA Approval of SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.1 SPRAVATO® is the first and only approved medicine that has been shown to reduce depressive symptoms within 24 hours,1 providing a new option for significant symptom relief until a longer-term, comprehensive treatment plan can take effect. Read more